Skip to main content
Top
Published in: BMC Nephrology 1/2019

Open Access 01-12-2019 | Chronic Kidney Disease | Research article

Creating a 13-year National Longitudinal Cohort of veterans with chronic kidney disease

Authors: Mukoso N. Ozieh, Mulugeta Gebregziabher, Ralph C. Ward, David J. Taber, Leonard E. Egede

Published in: BMC Nephrology | Issue 1/2019

Login to get access

Abstract

Background

The development of large-scale chronic kidney disease (CKD) cohorts within the Veterans Affairs (VA) system has been limited by several factors, including the high proportion of missing race data etc. The goal of this study is to address the limitations of prior studies by creating a large cohort utilizing robust KDIGO recommendations for identifying and staging CKD.

Methods

Multiple patient and administrative files from the Veterans Health Administration (VHA) National Patient Care were linked to create a national cohort of Veterans with chronic kidney disease (CKD) between January 2000 – December 2012; patients identified during this period were followed until 2015. CKD was defined for stages 1 through 5 if markers of kidney damage, specifically proteinuria, were present for at least 3 months. Estimated glomerular filtration rate (eGFR) values were calculated based on serum creatinine levels and the patient’s age, gender, and race using both the Modification of Diet in Renal Disease (MDRD) and Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) formulas.

Results

About 50 million observations were collected that supported a CKD diagnosis during the study period; these observations corresponded to 3,051,001 unique veterans; 80.9% were non-Hispanic white (NHW), 13.4% were non-Hispanic black (NHB), 3.6% were Hispanic, and 2.0% were in other groups. The mean age 76.7, about 97% were male and 50.2% died prior to January 2016. Among those with stage 3, 12.3% progressed to stage 4, 21.6% of those with stage 4 progressed to stage 5. We found that eGFR values calculated from serum creatinine levels identified about 98% of all patients, while about 11.4% of patients could be identified through ICD-9 codes; only 6.4% could be identified through both sources.

Conclusion

This 13-year national cohort provides an important resource for answering numerous research questions in the future such as racial/ethnic disparities questions, tracking health service utilization, medication adherence, cost and health outcomes in veterans with CKD.
Literature
1.
go back to reference Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 clinical practice guideline for the evaluation and Management of Chronic Kidney Disease. Kidney Int. 2013;3:1–150.CrossRef Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 clinical practice guideline for the evaluation and Management of Chronic Kidney Disease. Kidney Int. 2013;3:1–150.CrossRef
2.
go back to reference Levey AS, Atkins R, Coresh J, et al. Chronic kidney disease as a global public health problem: approaches and initiatives—a position statement from kidney disease improving global outcomes. Kidney Int. 2007;72:247–59.CrossRef Levey AS, Atkins R, Coresh J, et al. Chronic kidney disease as a global public health problem: approaches and initiatives—a position statement from kidney disease improving global outcomes. Kidney Int. 2007;72:247–59.CrossRef
3.
go back to reference Schieppati A, Remuzzi G. Chronic renal diseases as a public health problem: epidemiology, social, and economic implications. Kidney Int. 2005;68 (supp 98:S7–S10.CrossRef Schieppati A, Remuzzi G. Chronic renal diseases as a public health problem: epidemiology, social, and economic implications. Kidney Int. 2005;68 (supp 98:S7–S10.CrossRef
4.
5.
go back to reference U.S. Renal Data System (USRDS): USRDS 2013 annual Data report: atlas of chronic kidney disease and end-stage Renal disease in the United States, Bethesda, MD, National Institutes of Health, National Institute of diabetes and digestive and Kidney Diseases, 2013. U.S. Renal Data System (USRDS): USRDS 2013 annual Data report: atlas of chronic kidney disease and end-stage Renal disease in the United States, Bethesda, MD, National Institutes of Health, National Institute of diabetes and digestive and Kidney Diseases, 2013.
6.
go back to reference Couser WG, Remuzzi G, Mendis S, Tonelli M. The contribution of chronic kidney disease to the global burden of major non-communicable diseases. Kidney Int. 2011;80(12):1258–70.CrossRef Couser WG, Remuzzi G, Mendis S, Tonelli M. The contribution of chronic kidney disease to the global burden of major non-communicable diseases. Kidney Int. 2011;80(12):1258–70.CrossRef
7.
go back to reference Heron M. Deaths: Leading causes for 2014. National vital statistics reports; vol 65 no 5. Hyattsville: National Center for Health Statistics; 2016. Heron M. Deaths: Leading causes for 2014. National vital statistics reports; vol 65 no 5. Hyattsville: National Center for Health Statistics; 2016.
9.
go back to reference Navaneethan SD, Jolly SE, Schold JD, et al. Development and validation of an electronic health record-based chronic disease registry. Clin J Am Soc Nephrol. 2011;6(1):40–9.CrossRef Navaneethan SD, Jolly SE, Schold JD, et al. Development and validation of an electronic health record-based chronic disease registry. Clin J Am Soc Nephrol. 2011;6(1):40–9.CrossRef
10.
go back to reference Ronksley PE, Tonelli M, Quan H, et al. Validating a case definition for chronic kidney disease using administrative data. Nephrol Dial Transplant. 2011;0:1–6. Ronksley PE, Tonelli M, Quan H, et al. Validating a case definition for chronic kidney disease using administrative data. Nephrol Dial Transplant. 2011;0:1–6.
11.
go back to reference Gosmanova EO, Lu JL, Streja E, et al. Association of Medical Treatment non-Adherence with all-cause mortality in newly TreatedHypertensive US veterans. Hypertension. 2014;64(5):951–7.CrossRef Gosmanova EO, Lu JL, Streja E, et al. Association of Medical Treatment non-Adherence with all-cause mortality in newly TreatedHypertensive US veterans. Hypertension. 2014;64(5):951–7.CrossRef
12.
go back to reference Ravel V, Ahmadi SF, Streja E, et al. Pain and kidney function decline and mortality: a cohort study of US veterans. Am J Kidney Dis. 2016;68(2):240–6.CrossRef Ravel V, Ahmadi SF, Streja E, et al. Pain and kidney function decline and mortality: a cohort study of US veterans. Am J Kidney Dis. 2016;68(2):240–6.CrossRef
13.
go back to reference Levey AS, Bosch JP, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med. 1999;130:461–70.CrossRef Levey AS, Bosch JP, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med. 1999;130:461–70.CrossRef
14.
go back to reference Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–12.CrossRef Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–12.CrossRef
15.
go back to reference Maynard C, Chapko MK. Data resources in the Department of Veterans Affairs. Diabetes Care. 2004 May;27(Suppl 2):B22–6.CrossRef Maynard C, Chapko MK. Data resources in the Department of Veterans Affairs. Diabetes Care. 2004 May;27(Suppl 2):B22–6.CrossRef
16.
go back to reference Norris K, Mehrotra R, Nissenson AR. Racial differences in mortality and ESRD. Am J Kidney Dis. 2008 Aug;52(2):205–8.CrossRef Norris K, Mehrotra R, Nissenson AR. Racial differences in mortality and ESRD. Am J Kidney Dis. 2008 Aug;52(2):205–8.CrossRef
17.
go back to reference Little RJA, Rubin DB. Statistical analysis with missing Data. New York: Wiley; 2002.CrossRef Little RJA, Rubin DB. Statistical analysis with missing Data. New York: Wiley; 2002.CrossRef
18.
go back to reference Quan H, Sundararajan V, Halfon P, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care Nov. 2005;43(11):1130–9.CrossRef Quan H, Sundararajan V, Halfon P, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care Nov. 2005;43(11):1130–9.CrossRef
19.
go back to reference Levey AS, de Jong PE, Coresh J, et al. The definition, classification, and prognosis of chronic kidney disease: a KDIGO controversies conference report. Kidney Int. 2011;80:17–28.CrossRef Levey AS, de Jong PE, Coresh J, et al. The definition, classification, and prognosis of chronic kidney disease: a KDIGO controversies conference report. Kidney Int. 2011;80:17–28.CrossRef
20.
go back to reference Mahmoodi BK, Matsushita K, Woodward M, et al. Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without hypertension: a meta-analysis. Lancet. 2012;380:1649–61.CrossRef Mahmoodi BK, Matsushita K, Woodward M, et al. Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without hypertension: a meta-analysis. Lancet. 2012;380:1649–61.CrossRef
21.
go back to reference Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351:1296–305.CrossRef Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351:1296–305.CrossRef
22.
go back to reference Tangri N, Kitsios GD, Inker LA, et al. Risk prediction models for patients with chronic kidney disease. Ann Intern Med. 2013;158(8):596–603.CrossRef Tangri N, Kitsios GD, Inker LA, et al. Risk prediction models for patients with chronic kidney disease. Ann Intern Med. 2013;158(8):596–603.CrossRef
Metadata
Title
Creating a 13-year National Longitudinal Cohort of veterans with chronic kidney disease
Authors
Mukoso N. Ozieh
Mulugeta Gebregziabher
Ralph C. Ward
David J. Taber
Leonard E. Egede
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2019
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-019-1430-y

Other articles of this Issue 1/2019

BMC Nephrology 1/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.